Point72 Hong Kong LTD Rubius Therapeutics, Inc. Transaction History

Point72 Hong Kong LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.46 - $1.29 $798 - $2,238	1,735 New	1,735 $1,000
Q1 2022 May 16, 2022	SELL	$4.25 - $10.4 $20,412 - $49,951	-4,803 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$9.68 - $17.74 $16,523 - $30,282	1,707 Added 55.14%	4,803 $46,000
Q3 2021 Nov 15, 2021	BUY	$17.6 - $25.91 $54,489 - $80,217	3,096 New	3,096 $55,000
Q2 2021 Aug 16, 2021	SELL	$22.26 - $28.43 $7,768 - $9,922	-349 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$8.02 - $32.01 $2,798 - $11,171	349 New	349 $9,000
Q4 2019 Feb 14, 2020	SELL	$7.23 - $14.12 $253 - $494	-35 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$7.85 - $15.75 $274 - $551	35 New	35 $0

325

Ticker RUBY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,357,000
Description
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.